BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3805210)

  • 1. Determination of mofebutazone and its 4-hydroxy metabolite in plasma and urine by high-performance liquid chromatography.
    Delbeke FT; Debackere M
    J Chromatogr; 1986 Nov; 369(2):440-4. PubMed ID: 3805210
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous high-performance liquid chromatographic determination of suxibuzone and its metabolites in plasma and urine.
    Marunaka T; Shibata T; Minami Y; Umeno Y; Shindo T
    J Pharm Sci; 1980 Nov; 69(11):1258-61. PubMed ID: 7452452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology, toxicology and pharmacokinetics of mofebutazone].
    Loew D; Schuster O; Knoell HE; Graul EH
    Z Rheumatol; 1985; 44(4):186-92. PubMed ID: 4050150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of mofebutazone in plasma and synovial fluid].
    Kamp J; Loew D; Barkow D; Deister J; Schuster O; Knoell HE
    Z Rheumatol; 1984; 43(4):179-81. PubMed ID: 6495891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distribution of 4-14C-mofebutazone in the rat].
    Loew D; Schuster O; Graul EH
    Z Rheumatol; 1986; 45(2):83-6. PubMed ID: 3727816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Neto LM; Andraus MH; Salvadori MC
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of [4-14C] mofebutazone after oral administration in man.
    Kassem MA; Schulte KE
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):223-7. PubMed ID: 6519123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of four non-steroidal anti-inflammatory agents and their metabolites in plasma and urine by HPLC [proceedings].
    Thomas WO; Jefferies TM; Parfitt RT
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():91P. PubMed ID: 42771
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gas chromatographic determination of Feprazone in medicinal preparations].
    Gallazzi A; Vanoni PC
    Farmaco Prat; 1975 Mar; 30(3):147-52. PubMed ID: 1204822
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure of phenylbutazone and mofebutazone in the crystalline state and in solution.
    Paradies HH
    J Pharm Sci; 1987 Dec; 76(12):920-9. PubMed ID: 3440938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatographic assay of isoxicam in human plasma and urine.
    Bury RW
    J Chromatogr; 1985 Jan; 337(1):156-9. PubMed ID: 3980647
    [No Abstract]   [Full Text] [Related]  

  • 13. A gas-liquid chromatographic method for the quantitative determination of tolmetin in plasma and tolmetin and its major metabolite in urine.
    Selley ML; Thomas J; Triggs EJ
    J Chromatogr; 1974 Jul; 94(0):142-9. PubMed ID: 4844609
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.
    Bruce RB; Maynard WR; Dunning LK
    J Pharm Sci; 1974 Mar; 63(3):446-8. PubMed ID: 4820382
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of phenylbutazone and its metabolites by high performance liquid chromatography.
    Taylor JB; Lees P; Gerring EL
    Equine Vet J; 1981 Jul; 13(3):201-3. PubMed ID: 7297550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ketophenylbutazone metabolites in urine].
    Nĕmecek O; Macek K; Queisnerová M; Vejdĕlek ZJ
    Arzneimittelforschung; 1966 Oct; 16(10):1339-42. PubMed ID: 6014924
    [No Abstract]   [Full Text] [Related]  

  • 17. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
    Caturla MC; Cusido E
    J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
    Coppi G; Bonardi G; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:234-6. PubMed ID: 5067199
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of phenylbutazone, mofebutazone and aspirin on the pharmacokinetics of dexamethasone in the rat.
    Kassem MA; Schulte KE
    Eur J Drug Metab Pharmacokinet; 1981; 6(1):11-20. PubMed ID: 7250148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of proquazone and its m-hydroxy metabolite by high-performance liquid chromatography. Clinical application: pharmacokinetics of proquazone in children with juvenile rheumatoid arthritis.
    Lempiäinen M; Mäkelä AL
    J Chromatogr; 1985 May; 341(1):105-13. PubMed ID: 4019675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.